You are here

Bioiberica innovates with Dysgen®: early detection of genetic predisposition to hip dysplasia

31 Jan 2012
Companion Animal Health

Dysgen®, utilizes the innovative liquid DNA beadchip technology to simultaneously detect seven genetic markers associated with hip dysplasia.

Thanks to Dysgen®, a simple blood test is enough to find out if a pure breed Labrador retriever has genetic predisposition to hip dysplasia.

This information is critical for the early identification (within the first three weeks of age) of dogs having high probabilities of not developing hip dysplasia. In dogs with predisposition to hip dysplasia, the very early detection of the disease allows to select the most optimal monitoring program as well as to take preventive measures to delay the onset of hip dysplasia (personalized medicine).

Dysgen® is the answer to the needs of veterinarians, breeders and breed clubs, and, of course, to that of the pet owner.

Related News

Premio atopivet
4 Oct 2023
Companion Animal Health

This year's winning product was DermalEase/Atopivet drops and mousse - a topical skin care solution.

6 Sep 2023
Companion Animal Health

Pet food is constantly evolving, with new and innovative products being introduced to promote a healthier and more conscious nutrition for pets.

27 May 2020
Companion Animal Health
  • This marks yet another step forward in the internalisation strategy of this business unit's dedicated to companion animal health
  • The company has launched three products for joint and internal health: Condrovet® Force HA, Calmurofel® and Impromune®